After the close, NeurogesX, Inc. (Nasdaq: NGSX) announced today that the FDA has approved Qutenza 8% patch, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE